source
- Beeline ups its Series A round for immune drug workThe company, which was built by Bain Capital, has now raised more than $426 million in its quest to advance a portfolio of Bristol Myers drugs.BioPharma Dive · 1mo ago↗ source
- STAT+: All of Us tests a new approach to collect real-world data for researchThe NIH All of Us Research Program has secured thousands of electronic medical records through an innovative use of patient data-sharing networksSTAT · 1mo ago↗ source
- Top FDA gene and cell therapy regulator to step downFollowing Vijay Kumar’s exit, acting CBER Director Karim Mikhail will also oversee a review office that has become a battleground for debates on FDA flexibility.BioPharma Dive · 1mo ago↗ source